专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

51. 发明申请

US20220072227A1 BLOOD GLUCOSE CONTROL SYSTEM SWITCHING WITHOUT INTERRUPTION OF THERAPY DELIVERY 有权
公开(公告)号：US20220072227A1
公开(公告)日：2022-03-10
申请号：US17478071
申请日：2021-09-17
申请人： Beta Bionics, Inc.
发明人： Himanshu Patel , Michael J. Rosinko , Edward R. Damiano , David Chi-Wai Lim , Firas H. El-Khatib , John R. Costik , Justin P. Brown , Bryan Dale Knodel
IPC分类号： A61M5/172 , G16H20/17 , G16H40/40 , G06F8/656 , H04W76/10 , A61M5/142 , G06F8/61 , H04L29/08 , G16H40/60 , G16H80/00 , A61M5/168 , G08B21/04 , G08B21/18 , G16H40/67 , G06F21/30 , G06F21/31 , G06F21/62 , G06F21/84 , G16H10/60 , G16H50/30 , G06F3/0488 , G06F8/65 , H04L29/06 , H04W76/14 , H04L9/08 , H04L9/30 , G06F3/0484
摘要： Systems and methods are disclosed herein for switching an application executing on an ambulatory medical device to a new application without interrupting therapy provided by the ambulatory medical device to a subject. The ambulatory medical device may receive an indication that an update to an application executing on the ambulatory insulin pump is available, establish a communication connection to a host computing system, download and install the application update, while a prior version of the application continues to run. The disclosed systems and methods can confirm successful installation of the application update on the ambulatory medical device and switch control of the ambulatory medical device from the prior version to the new version of the application without interrupting therapy provided to the subject.

52. 发明授权

US11154656B2 Blood glucose control system with medicament bolus recommendation 有权
公开(公告)号：US11154656B2
公开(公告)日：2021-10-26
申请号：US17062436
申请日：2020-10-02
申请人： Beta Bionics, Inc.
发明人： Firas H. El-Khatib , Edward R. Damiano , Edward B. Raskin , David Chi-Wai Lim , Michael J. Rosinko , John R. Costik
IPC分类号： A61M5/172 , A61M5/142 , G16H20/17 , G16H40/40 , G06F8/656 , H04W76/10 , G06F8/61 , H04L29/08 , G16H40/60 , G16H80/00 , A61M5/168 , G08B21/04 , G08B21/18 , G16H40/67 , G06F21/30 , G06F21/31 , G06F21/62 , G06F21/84 , G16H10/60 , G16H50/30 , G06F3/0488 , G06F8/65 , H04L29/06 , H04W76/14 , H04L9/08 , H04L9/30 , G06F3/0484 , G08B25/00 , A61B5/145 , G16H40/00
摘要： An automated blood glucose control system can provide automatic delivery of glucose control therapy to a subject and receive information about manual glucose control therapy provided to the subject. The automated blood glucose control system can indicate an amount of a bolus of medicament via a control algorithm configured to control blood glucose level in the subject. The automated blood glucose control system can indicate an amount of a manual bolus of medicament, which can be used to model a diminishment of the medicament in the subject over time based at least in part on the manual bolus of medicament.

53. 发明申请

US20210090726A1 AMBULATORY MEDICAL DEVICE UPDATE WITHOUT INTERRUPTION OF THERAPY DELIVERY 有权
公开(公告)号：US20210090726A1
公开(公告)日：2021-03-25
申请号：US17062356
申请日：2020-10-02
申请人： Beta Bionics, Inc.
发明人： Michael J. Rosinko , Edward R. Damiano , David Chi-Wai Lim , Firas H. El-Khatib , Himanshu Patel , John R. Costik , Justin P. Brown , Bryan Dale Knodel
IPC分类号： G16H40/40 , G16H20/17 , G16H40/67 , A61M5/142
摘要： Systems and methods are disclosed herein for updating an application controlling an ambulatory medical device such that application updates can be identified, downloaded and installed without interrupting therapy provided by the ambulatory medical device to a subject. The ambulatory medical device may receive an indication that an update to an application executing on the ambulatory insulin pump is available, establish a communication connection to a host computing system configured to host the application update, and download the application update. The disclosed systems and methods can determine an execution time of an installation and install the downloaded application update without interrupting therapy provided by the ambulatory medical device to the subject.

54. 发明申请

US20210090706A1 AMBULATORY MEDICAMENT DEVICE WITH ALARM STATUS INDICATION 有权
公开(公告)号：US20210090706A1
公开(公告)日：2021-03-25
申请号：US17062353
申请日：2020-10-02
申请人： Beta Bionics, Inc.
发明人： Michael J. Rosinko , Edward R. Damiano , David Chi-Wai Lim , Firas H. El-Khatib , Justin P. Brown , Bryan Dale Knodel
IPC分类号： G16H20/17 , G08B21/18 , G06F3/0488 , G16H40/67 , G16H10/60 , G16H40/40 , G16H50/30 , H04L29/06 , G06F8/65 , A61M5/142 , A61M5/172
摘要： Systems and methods are disclosed herein for monitoring the status of an ambulatory medical device and the health condition of a subject that receives therapy from the ambulatory medical device. The ambulatory medical device can have a touchscreen display user interface to receive input signals from a user and display alarm conditions associated with the status of an ambulatory medical device or health condition of a subject. The disclosed methods and systems can determine whether status information received from a monitoring system interface satisfies an alarm condition for the ambulatory medicament device or for the subject. If the status information satisfies an alarm condition, the touchscreen user interface can display one or more alarm status indicators corresponding to the alarm condition. The user can activate a therapy change interface on the touchscreen display and modify a control parameter of the ambulatory medical device that controls the therapy delivery to the subject.

55. 发明申请

US20210085869A1 BLOOD GLUCOSE CONTROL SYSTEM WITH MEDICAMENT BOLUS RECOMMENDATION 有权
公开(公告)号：US20210085869A1
公开(公告)日：2021-03-25
申请号：US17062436
申请日：2020-10-02
申请人： Beta Bionics, Inc.
发明人： Firas H. El-Khatib , Edward R. Damiano , Edward B. Raskin , David Chi-Wai Lim , Michael J. Rosinko , John R. Costik
IPC分类号： A61M5/172 , A61M5/142
摘要： An automated blood glucose control system can provide automatic delivery of glucose control therapy to a subject and receive information about manual glucose control therapy provided to the subject. The automated blood glucose control system can indicate an amount of a bolus of medicament via a control algorithm configured to control blood glucose level in the subject. The automated blood glucose control system can indicate an amount of a manual bolus of medicament, which can be used to model a diminishment of the medicament in the subject over time based at least in part on the manual bolus of medicament.

56. 发明申请

US20210085868A1 AMBULATORY MEDICAMENT DEVICE WITH AUTOMATIC RESUMPTION OF MEDICAMENT DELIVERY 有权
公开(公告)号：US20210085868A1
公开(公告)日：2021-03-25
申请号：US17062426
申请日：2020-10-02
申请人： Beta Bionics, Inc.
发明人： David Chi-Wai Lim , Edward B. Raskin , Michael J. Rosinko , Edward R. Damiano , Firas H. El-Khatib , Himanshu Patel
IPC分类号： A61M5/172 , A61M5/142
摘要： An ambulatory medicament device can automatically resume medicament delivery after medicament delivery to a subject is suspended. Suspension of medicament delivery can occur for a temporary suspension period associated with a length of time that the delivery of the medicament is to be suspended. Resuming medicament delivery can occur upon determining that a resumption condition has occurred during the temporary suspension period.

57. 发明申请

US20210016005A1 BLOOD GLUCOSE CONTROL SYSTEM WITH AUTOMATED BACKUP THERAPY PROTOCOL GENERATION 有权
公开(公告)号：US20210016005A1
公开(公告)日：2021-01-21
申请号：US17061990
申请日：2020-10-02
申请人： BETA BIONICS, INC.
发明人： Edward B. Raskin , David Chi-Wai Lim , Michael J. Rosinko , Firas H. El-Khatib , Edward R. Damiano
IPC分类号： A61M5/172 , G16H20/17 , G16H10/40 , G16H40/67
摘要： An automated blood glucose control system is configured to generate a backup therapy protocol comprising insulin therapy instructions derived from autonomously determined doses of insulin. The system generates a dose control signal using a control algorithm configured to autonomously determine doses of insulin to be infused into a subject for the purpose of controlling blood glucose of the subject based at least in part on a glucose level signal received from a glucose sensor. The system can track insulin therapy administered to the subject over a tracking period, including storing an indication of the autonomously determined doses of insulin delivered to the subject as basal insulin, as correction boluses of insulin, or as mealtime boluses of insulin. The system can generate a backup injection therapy protocol or a backup pump therapy protocol with insulin therapy instructions based at least in part on the insulin therapy administered to the subject over the tracking period.

58. 外观设计

USD1032624S1 Display screen with animated graphical user interface 有权
公开(公告)号：USD1032624S1
公开(公告)日：2024-06-25
申请号：US29776063
申请日：2021-03-26
申请人： Beta Bionics, Inc.
设计人： David Chi-Wai Lim , Edward R. Damiano , Michael J. Rosinko , Mads Henrik Dall
摘要： This invention was made with U.S. government support under Contract No. DK120234, awarded by the National Institutes of Health. The government has certain rights in the invention.
FIG. 1 is a front view of a first image of a first embodiment of a display screen with animated graphical user interface embodying the new design;
FIG. 2 is a front view of a second image thereof;
FIG. 3 is a front view of a third image thereof;
FIG. 4 is a front view of a fourth image thereof; and
FIG. 5 is a front view of a fifth image thereof.
FIG. 5 is a front view of a first image of a second embodiment of a display screen with animated graphical user interface embodying the new design;
FIG. 4 is a front view of a second image thereof;
FIG. 3 is a front view of a third image thereof;
FIG. 2 is a front view of a fourth image thereof; and,
FIG. 1 is a front view of a fifth image thereof.
The broken line showing of a display screen with graphical user interface is included for the purpose of showing portions of the article which form no part of the claim. Solid black portions indicate a contrast in appearance.
The appearance of the transitional image of a first embodiment of the claimed design sequentially transitions between the images shown in FIGS. 1-5. The appearance of the transitional image of a second embodiment of the claimed design sequentially transitions between the images shown in FIGS. 5-1. The process or period in which one image transitions to another image forms no part of the claimed design.

59. 外观设计

USD1031975S1 Medicament infusion pump device 有权
公开(公告)号：USD1031975S1
公开(公告)日：2024-06-18
申请号：US29776660
申请日：2021-03-31
申请人： Beta Bionics, Inc.
设计人： Bryan Dale Knodel , David Matthew Henderson , Edward R. Damiano , Michael J. Rosinko
摘要： FIG. 1 is a front, first side, and top isometric view of a first embodiment of a medicament infusion pump device embodying the new design;
FIG. 2 is a front, first side, and bottom isometric view thereof;
FIG. 3 is a front view thereof;
FIG. 4 is a rear view thereof;
FIG. 5 is a first side view thereof;
FIG. 6 is a second side view thereof;
FIG. 7 is a top view thereof; and,
FIG. 8 is a bottom view thereof.
The equal-length broken lines in the drawings depict portions of the medicament infusion pump device that form no part of the claimed design. The equal-length broken lines showing cords depict environment and form no part of the claimed design. All broken lines form no part of the claim.

60. 发明授权

US11941392B2 Ambulatory medical device with malfunction alert prioritization 有权
公开(公告)号：US11941392B2
公开(公告)日：2024-03-26
申请号：US17486517
申请日：2021-09-27
申请人： Beta Bionics, Inc.
发明人： Michael J. Rosinko , Himanshu Patel , Edward R. Damiano , Firas H. El-Khatib , David Chi-Wai Lim
IPC分类号： A61M5/172 , A61M5/142 , A61M5/168 , G06F3/04847 , G06F3/04883 , G06F8/61 , G06F8/65 , G06F8/656 , G06F21/30 , G06F21/31 , G06F21/62 , G06F21/84 , G08B21/04 , G08B21/18 , G16H10/60 , G16H20/17 , G16H40/40 , G16H40/60 , G16H40/67 , G16H50/30 , G16H80/00 , H04L9/08 , H04L9/30 , H04L9/40 , H04L67/00 , H04W76/10 , H04W76/14 , A61B5/145 , G08B25/00 , G16H40/00
CPC分类号： G06F8/656 , A61M5/142 , A61M5/14244 , A61M5/14248 , A61M5/16831 , A61M5/172 , G06F3/04847 , G06F3/04883 , G06F8/61 , G06F8/65 , G06F21/305 , G06F21/31 , G06F21/6245 , G06F21/84 , G08B21/0453 , G08B21/18 , G16H10/60 , G16H20/17 , G16H40/40 , G16H40/60 , G16H40/67 , G16H50/30 , G16H80/00 , H04L9/088 , H04L9/30 , H04L63/101 , H04L67/34 , H04W76/10 , H04W76/14 , A61B5/14532 , A61M2005/14208 , A61M5/1723 , A61M2005/1726 , A61M2205/18 , A61M2205/3327 , A61M2205/3546 , A61M2205/3553 , A61M2205/3584 , A61M2205/3592 , A61M2205/50 , A61M2205/502 , A61M2205/505 , A61M2205/52 , A61M2205/581 , A61M2205/582 , A61M2205/583 , A61M2205/609 , A61M2230/201 , G08B25/00 , G16H40/00
摘要： An ambulatory medical device can detect a device condition and determine if the device condition satisfies a set of normal operating parameters. If the normal operating parameters are not satisfied, the ambulatory medical device can determine if the device condition stratifies a set of minimum operating parameters. If the minimum operating parameters are satisfied, the ambulatory medical device can maintain a delivery of therapy to a subject and generate an alert based on the device condition.

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式